RNA Controls
HORIZON DISCOVERY BIOSCIENCES LIMITED EDIT-R PREDESIGNED SYNTHETIC
NC3718197 EDIT-R PREDESIGNED SYNTHETIC
HORIZON DISCOVERY BIOSCIENCES LIMITED EDIT-R LETHAL SYNTHETIC SGRNA
NC3450601 EDIT-R LETHAL SYNTHETIC SGRNA
HORIZON DISCOVERY BIOSCIENCES LIMITED EDIT-R HUM SYNTH FBXW11 SET/3
NC3734243 EDIT-R HUM SYNTH FBXW11 SET/3
Cell Signaling Technology PathScanR Total S6 Ribosomal Protein Chemiluminescent Sandwich ELISA Kit 10 Kit
PathScanR Total S6 Ribosomal Protein Chemiluminescent Sandwich ELISA Kit 10 Kit
Medchemexpress LLC Erythropoietin (EPO) | 11096-26-7 | >95.0% | 20UG
Recombinant human erythropoietin (EPO) expressed in HEK293 cells, tag-free and supplied as a lyophilized powder. The protein retains mammalian glycosylation important for activity and is formulated from filtered PBS with trehalose stabilizer. It is suitable for biochemical assays, receptor binding, and cell-based erythropoiesis studies.
- Expression system: HEK293 cells
- Tag: tag-free
- Amount: 20 μg (lyophilized)
- Purity: >95.0% (by PAGE or SEC-HPLC)
- Molecular weight: approximately 28-45 kDa (glycosylated)
- Endotoxin: <1 EU/μg
- Formulation: lyophilized from 0.22 μm filtered PBS with trehalose
- Applications: biochemical assays and cell-based erythropoiesis studies
HORIZON DISCOVERY BIOSCIENCES LIMITED EDIT-R KPNA3 SGRNA1 10NMOL
NC3854405 EDIT-R KPNA3 SGRNA1 10NMOL
Medchemexpress LLC Erythropoietin (EPO) protein, human (HEK293) | 11096-26-7 | 50UG
Recombinant human erythropoietin produced in HEK293 cells, supplied as a lyophilized, tag-free protein for research use. The glycosylated protein corresponds to amino acids A28-R193 and demonstrates bioactivity in TF-1 cell proliferation assays (ED50 0.4-1 ng/mL).
Supply Solutions Roche - Protector RNase Inhibitor, 10 000 U; pkg of 10,000 U (03335402001 [5x2,000 U]) pkg of 2,000 U (03335399001)
Roche - Protector RNase Inhibitor, 10 000 U; pkg of 10,000 U (03335402001 [5x2,000 U]) pkg of 2,000 U (03335399001)